1. Home
  2. PAVS vs ACXP Comparison

PAVS vs ACXP Comparison

Compare PAVS & ACXP Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Paranovus Entertainment Technology Ltd.

PAVS

Paranovus Entertainment Technology Ltd.

N/A

Current Price

$2.56

Market Cap

5.5M

Sector

Health Care

ML Signal

N/A

Logo Acurx Pharmaceuticals Inc.

ACXP

Acurx Pharmaceuticals Inc.

N/A

Current Price

$1.07

Market Cap

6.2M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
PAVS
ACXP
Founded
2004
2017
Country
United States
United States
Employees
N/A
N/A
Industry
Medicinal Chemicals and Botanical Products
Biotechnology: Pharmaceutical Preparations
Sector
Health Care
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
5.5M
6.2M
IPO Year
2018
2021

Fundamental Metrics

Financial Performance
Metric
PAVS
ACXP
Price
$2.56
$1.07
Analyst Decision
Strong Buy
Analyst Count
0
3
Target Price
N/A
★ $17.00
AVG Volume (30 Days)
10.4K
★ 71.3K
Earning Date
12-04-2026
11-12-2026
Dividend Yield
N/A
N/A
EPS Growth
★ N/A
N/A
EPS
★ N/A
N/A
Revenue
N/A
N/A
Revenue This Year
$541.46
N/A
Revenue Next Year
$1.00
N/A
P/E Ratio
N/A
★ N/A
Revenue Growth
N/A
N/A
52 Week Low
$0.02
$1.07
52 Week High
$26.69
$7.54

Technical Indicators

Market Signals
Indicator
PAVS
ACXP
Relative Strength Index (RSI) 28.74 27.23
Support Level $1.09 N/A
Resistance Level $4.64 $1.75
Average True Range (ATR) 0.18 0.06
MACD -0.03 -0.01
Stochastic Oscillator 19.13 4.00

Price Performance

Historical Comparison
PAVS
ACXP

About PAVS Paranovus Entertainment Technology Ltd.

Paranovus Entertainment Technology Ltd, through its subsidiaries, is involved in the AI-powered entertainment industry, to provide users with AI-driven games and applications to deliver immersive and engaging entertainment experiences. It has entered into a software development agreement for the development of 10,000 Lives, a mobile game where players pursue various careers and life goals using a board game mechanic. The group is also involved in an e-commerce business and provides TikTok-related e-commerce solutions for customers.

About ACXP Acurx Pharmaceuticals Inc.

Acurx Pharmaceuticals Inc is a late-stage biopharmaceutical company focused on developing a new class of small-molecule antibiotics for difficult-to-treat bacterial infections. Its approach is to develop antibiotic candidates with a Gram-positive selective spectrum (GPSS) that block the active site of the Gram-positive specific bacterial enzyme deoxyribonucleic acid (DNA) polymerase IIIC (pol IIIC), inhibiting DNA replication and Gram-positive bacterial cell death. Its research and development pipeline includes antibiotic product candidates targeting Gram-positive bacteria, including Clostridioides difficile, methicillin-resistant Staphylococcus aureus, vancomycin-resistant Enterococcus, and drug-resistant Streptococcus pneumoniae and B. anthracis. It operates in a single segment.

Share on Social Networks: